Although the overall PDGFRA mutation frequency in gliomas is relatively low (1%, TCGA), PDGFRA mutations are exclusively observed in rapidly growing high-grade gliomas7 and tumors with PDGFRA amplification (12–40%)7,8. This evidence concerns the gene PDGFRA and central nervous system cancer.